Metastatic Breast Cancer: Overview of Treatment

Suhail M. Ali, H. A. Harvey, Allan Lipton

Research output: Contribution to journalArticle

43 Scopus citations


Patients with metastatic breast cancer have a median survival of 2 to 3 years. Twenty percent of the patients who present with bone-only metastasis will be alive at 5 years from diagnosis. Current therapies are aimed at improving the quality of life, symptom control, and prolongation of survival. Newer endocrine and chemotherapeutic drugs are available to the medical oncologist for care of patients with metastatic breast cancer. We will briefly review the new advances in the treatment of metastatic breast cancer.

Original languageEnglish (US)
Pages (from-to)S132-S137
JournalClinical orthopaedics and related research
Issue number415 SUPPL.
Publication statusPublished - Oct 2003


All Science Journal Classification (ASJC) codes

  • Surgery
  • Orthopedics and Sports Medicine

Cite this